
The Future of Colorectal Cancer Screening: Reaching the Unscreened
10.9.2026
0:00
22:46
In this episode, Dr. AmirAli Talasaz, Co-Founder and Co-CEO of Guardant Health, discusses how blood-based screening can help close persistent colorectal cancer screening gaps and reach millions of unscreened patients. He also explores how the Shield Blood Test can increase screening participation, reconnect unscreened patients with health systems and enable earlier detection of colorectal cancer, particularly in rural and underserved communities.
This episode is sponsored by Guardant Health.
Weitere Episoden von „Becker’s Healthcare Podcast“



Verpasse keine Episode von “Becker’s Healthcare Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








